A pioneering treatment that can reverse a form of childhood vision loss by inserting DNA directly into the eye is on track for regulatory approval in the US, after a panel of scientists endorsed unanimously the “gene therapy” being developed by Spark Therapeutics.
一種將DNA直接植入眼睛以逆轉(zhuǎn)某類兒童視力喪失的開(kāi)創(chuàng)性療法，有望得到美國(guó)監(jiān)管機(jī)構(gòu)的批準(zhǔn)。此前，一個(gè)由科學(xué)家組成的顧問(wèn)委員會(huì)對(duì)這種由Spark Therapeutics研發(fā)的“基因療法”表示了一致的支持。
您已閱讀15%（365字），剩余85%（2138字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。